Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday.
from WebMD Health https://ift.tt/G5J9m1f
Wednesday, 8 June 2022
Moderna Finds ‘Robust Antibody Response’ in Omicron-Specific Booster
from WebMD Health https://ift.tt/G5J9m1f
0 comments:
Post a Comment